Quick Read
- The 2025-2026 flu season is exceptionally severe, with flu-like illness visits reaching a nearly 30-year high.
- The dominant strain is a new variant, influenza A H3N2 subclade K, dubbed the ‘super flu,’ accounting for about 90% of cases.
- Hospitals and ERs nationwide are overwhelmed, with record high hospitalizations in states like New York.
- New symptoms observed include gastrointestinal complaints (vomiting, diarrhea), shortness of breath, and low oxygen levels.
- The 2025-2026 flu shot provides cross-protection against subclade K and is still recommended, despite a slight mismatch.
The 2025-2026 flu season has unleashed an unprecedented wave of illness across the United States, pushing healthcare systems to their breaking point. As millions returned from holiday gatherings, the influenza virus, particularly a new variant dubbed the ‘super flu,’ has rapidly spread, leading to hospitalization rates not seen in nearly three decades. Doctors and public health officials are grappling with overflowing emergency rooms and a surge in complications, all while new, less common symptoms are emerging, challenging traditional perceptions of influenza.
The ‘Super Flu’ Strain: A Tougher Adversary
At the heart of this severe season is influenza A H3N2, specifically a mutated strain known as subclade K. This variant, which caused early and severe outbreaks in regions like Japan and the United Kingdom, now accounts for roughly 90% of cases in the U.S. While the World Health Organization notes there’s no data suggesting subclade K is inherently more dangerous than other H3N2 strains, its seven new mutations appear to be adept at evading pre-existing immunity, whether from past infections or vaccinations. Dr. Scott Roberts, an assistant professor of infectious diseases at the Yale School of Medicine, explained to TODAY.com, “There’s no indication this is a more severe strain. But it’s slightly more mutated than what our immune system recognizes and expects, so there’s increased numbers of people getting infected than previous years.” This slight evolutionary edge has translated into a much larger pool of susceptible individuals, fueling the rapid escalation of cases.
This season marks a stark departure from recent years, with flu activity reaching ‘high’ or ‘very high’ levels in at least 41 states. Outpatient visits for flu-like symptoms soared to 8.2% by early January, the highest recorded since the 1997-1998 flu season. The U.S. Centers for Disease Control and Prevention (CDC) estimates over 15 million illnesses, 180,000 hospitalizations, and 7,400 deaths so far this season, including 17 children. These figures already surpass the 2024-2025 epidemic, which was itself deemed a ‘high severity’ season. Dr. Michael Phillips, director of the Division of Infectious Diseases at NYU Grossman School of Medicine, described it as “an unusual season. It’s been severe, with a rapid onset.”
Hospitals Overwhelmed: A System Under Strain
The sheer volume of flu cases has placed immense pressure on healthcare facilities nationwide. In densely populated areas like New York City, flu-related hospitalizations hit an all-time weekly high, with emergency departments “packed,” as Dr. Phillips observed. Beyond active flu cases, there’s been a significant influx of post-flu complications, such as pneumonia, further straining resources. Connecticut is experiencing a similar surge, with Dr. Roberts noting that adding “100 flu patients on top of that” to hospitals already operating at 95% capacity inevitably strains the system. In South Carolina, one hospital system was so overwhelmed it resorted to restricting patient visitors, according to WSAV.
Children, in particular, are bearing a heavy burden this season. North Carolina reported the first pediatric flu death of the 2025-2026 season, and Dr. Daniel Park, medical director of UNC Children’s emergency department, described his hospital as “bursting at the seams.” The overflow has led to longer wait times and limited bed space, forcing medical staff to “get creative in creating space in every crevice of the emergency department.” This situation is compounded by the fact that hospitals are also contending with other circulating viruses like COVID-19, RSV, and norovirus, creating a perfect storm of respiratory illness.
Beyond the Cough: Emerging Flu Symptoms
While many classic flu symptoms remain prevalent, healthcare providers are reporting some notable shifts this season. Dr. Linda Yancey, an infectious disease hospitalist at Memorial Hermann Houston, confirmed to TODAY.com that “the symptoms are remarkably similar to previous years.” These familiar signs include fever, chills, extreme fatigue, body aches, sore throat, cough, and a stuffy or runny nose. The flu often strikes suddenly and intensely, leaving individuals feeling “like you’ve been hit by a truck,” as Yancey vividly put it.
However, this season has seen an increase in gastrointestinal complaints. Dr. Park noted, “This flu season, we’ve also been seeing a lot of GI complaints, like vomiting and diarrhea.” Additionally, ER doctors have observed more flu patients presenting with shortness of breath and low oxygen levels, indicating a potentially more severe respiratory impact in some cases. These emerging symptoms underscore the importance of seeking timely medical attention, especially for high-risk individuals.
Flu symptoms typically last from a few days to two weeks, with most people recovering on their own. Antiviral medications, if started within 48 hours of symptom onset, can lessen the severity and duration of illness. PCR tests remain the gold standard for diagnosis, but at-home flu tests offer a quicker, though less accurate, option for those with mild symptoms, allowing them to stay home and avoid overwhelming emergency rooms.
Vaccination and Prevention: Your Best Defense
Despite the challenges posed by subclade K, experts unequivocally emphasize that it is not too late to get a flu shot. The 2025-2026 flu vaccine covers three viruses: influenza A H3N2, influenza A H1N1, and influenza B. While subclade K emerged after the vaccine strains were finalized, leading to a slight mismatch with the H3N2 component, the vaccine still offers crucial cross-protection. Dr. Roberts assured, “The vaccine is still going to offer cross-protection. It just won’t be as robust as what we wanted.” The flu shot significantly reduces severe illness, hospitalizations, and deaths, particularly for high-risk groups, including individuals over 65, children under two, and those with compromised immune systems or underlying health conditions.
Early data from the UK’s Health Security Agency suggests the 2025-2026 vaccine is about 70-75% effective at reducing hospitalizations among children. Moreover, the vaccine components for H1N1 and flu B strains are well-matched to circulating viruses. Flu season typically extends into March or April, providing ample time to benefit from vaccination.
A significant change this season is the CDC’s updated recommendation for children’s flu shots. While previously universally recommended, it’s now listed under “shared clinical decision-making,” requiring parents to consult a healthcare provider. The American Academy of Pediatrics called this change “dangerous,” especially given that 89% of pediatric flu deaths last season were among unvaccinated children. Beyond vaccination, basic preventive measures remain critical: frequent hand washing, avoiding touching the face, staying home when sick, avoiding close contact with ill individuals, wearing masks in high-risk settings, and disinfecting surfaces.
This flu season is a stark reminder of influenza’s unpredictable nature and its continued capacity to challenge public health. The emergence of new symptoms like GI issues and the overwhelming strain on hospitals highlight the critical need for continued vigilance, widespread vaccination, and adaptable public health strategies to mitigate the impact of evolving viral threats.